Oxymetazoline
| Use attributes for filter ! | |
| CAS ID | 1491-59-4 |
|---|---|
| Formula | C16H24N2O |
| Trade name | Afrin, Ocuclear, Drixine |
| Elimination half-life | 5–6 hours |
| Metabolism | Kidney (30%), fecal (10%) |
| Dependence liability | Moderate |
| Music groups | Xylometazoline |
| Fluticasone | |
| Naphazoline | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2173484 |
About Oxymetazoline
Oxymetazoline is a selective α₁ adrenergic receptor agonist and α₂ adrenergic receptor partial agonist. It is a topical decongestant, used in the form of oxymetazoline hydrochloride. It was developed from xylometazoline at E. Merck Darmstadt by Fruhstorfer in 1961.